Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Denatured collagen triple-helix motifs are structural signatures of degraded or unfolded collagen fibers within the extracellular matrix (ECM). In healthy tissues, collagen exists as a stable, tightly packed triple helix; however, pathological conditions such as cancer, inflammation, and mechanical injury trigger the denaturation of these helices into disordered single strands (Hwang et al., 2017, ACS Nano). These motifs expose "cryptic" sites that are normally hidden, making them unique biochemical markers for active tissue remodeling and disease progression (Bennink et al., 2018, Nature Communications). Because these motifs are virtually absent in healthy, intact basement membranes and connective tissues, they provide a highly specific target for diagnostic imaging and site-specific drug delivery. Therapeutic approaches often utilize Collagen Hybridizing Peptides (CHPs), which are synthetic sequences that specifically bind to denatured collagen by reforming the triple-helical structure through hydrogen bonding (Li & Yu, 2013, Soft Matter). This interaction allows for the selective targeting of tumors and fibrotic lesions where matrix metalloproteinase (MMP) activity is high. Beyond oncology, these motifs are significant in studying and treating osteoarthritis and cardiovascular diseases characterized by ECM breakdown.
Triple-helix hybridization: Synthetic peptides (CHPs) or specific antibodies bind to exposed single-stranded collagen alpha-chains. CHPs specifically reform the triple-helical structure through hydrogen bonding with the unfolded strands, while antibodies recognize cryptic epitopes exposed only upon denaturation (Li & Yu, 2013, Soft Matter; Xu et al., 2001, Journal of Cell Biology).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Denatured collagen triple-helix motifs.